Your treatment priorities are at the core of a special initiative called “More Than Skin Deep”.
Global Parents for Eczema Research has partnered with four nonprofit organizations to create a series of opportunities for your perspective to inform and shape development of drugs and medical devices designed to treat eczema.
We will jointly hold a patient-focused drug development (PFDD) meeting on September 23, 2019 in the Washington, D.C. area. It will help staff at the U.S. Food and Drug Administration (FDA) and clinical trial sponsors understand more fully the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative! Visit www.MoreThanSkinDeep-eczema.org to learn how you can get involved by participating in the meeting (in person or by webcast) and responding to a new survey.
Global Parents for Eczema Research has partnered with four nonprofit organizations to create a series of opportunities for your perspective to inform and shape development of drugs and medical devices designed to treat eczema.
We will jointly hold a patient-focused drug development (PFDD) meeting on September 23, 2019 in the Washington, D.C. area. It will help staff at the U.S. Food and Drug Administration (FDA) and clinical trial sponsors understand more fully the burdens of living with eczema, what patients and caregivers most value in terms of treatment benefits, and what risks and side effects they are willing to tolerate. Be part of this landmark initiative! Visit www.MoreThanSkinDeep-eczema.org to learn how you can get involved by participating in the meeting (in person or by webcast) and responding to a new survey.